Contact
Please use this form to send email to PR contact of this press release:
EBCI Brings Awareness to How Newly Diagnosed Glioblastoma Patients Can Access Imvax’s Clinical Study
TO:
Dellann Elliott Mydland
End Brain Cancer Initiative
+1 425-444-2215